Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.755 USD | -1.82% | +0.01% | +3.41% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.43% | 20.77M | |
+6.12% | 101B | |
+1.57% | 30.48B | |
+9.74% | 21.41B | |
-19.47% | 19.29B | |
-5.27% | 17.4B | |
+0.93% | 14.21B | |
-6.68% | 12.02B | |
-2.98% | 10.49B | |
-10.66% | 8.99B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Alpine 4 Holdings Receives Non-Compliance Notice From Nasdaq